655 related articles for article (PubMed ID: 8605964)
1. Flow cytometric analysis of human bone marrow perfusion cultures: erythroid development and relationship with burst-forming units-erythroid.
Rogers CE; Bradley MS; Palsson BO; Koller MR
Exp Hematol; 1996 Apr; 24(5):597-604. PubMed ID: 8605964
[TBL] [Abstract][Full Text] [Related]
2. Human interleukin (IL)-9 specifically stimulates proliferation of CD34+++DR+CD33- erythroid progenitors in normal human bone marrow in the absence of serum.
Lu L; Leemhuis T; Srour EF; Yang YC
Exp Hematol; 1992 May; 20(4):418-24. PubMed ID: 1373687
[TBL] [Abstract][Full Text] [Related]
3. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
Mayani H; Guilbert LJ; Janowska-Wieczorek A
Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric characterization of perfused human bone marrow cultures: identification of the major cell lineages and correlation with the CFU-GM assay.
Brott DA; Maher RJ; Parrish CR; Richardson RJ; Smith AK
Cytometry A; 2003 May; 53(1):22-7. PubMed ID: 12701129
[TBL] [Abstract][Full Text] [Related]
5. Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxin.
Benedetti G; Bondesan P; Caracciolo D; Cherasco C; Ruggieri D; Gastaldi ME; Pileri A; Gianni AM; Tarella C
Exp Hematol; 1994 Feb; 22(2):166-73. PubMed ID: 7507858
[TBL] [Abstract][Full Text] [Related]
6. Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro.
Cipolleschi MG; D'Ippolito G; Bernabei PA; Caporale R; Nannini R; Mariani M; Fabbiani M; Rossi-Ferrini P; Olivotto M; Dello Sbarba P
Exp Hematol; 1997 Oct; 25(11):1187-94. PubMed ID: 9328456
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
8. B-lymphocyte-derived burst-promoting activity is a pleiotropic erythroid colony-stimulating factor, E-CSF.
Feldman L; Frazier JG; Sytkowski AJ
Exp Hematol; 1992 Nov; 20(10):1223-8. PubMed ID: 1426102
[TBL] [Abstract][Full Text] [Related]
9. Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin.
Aoki I; Taniyama M; Toyama K; Homori M; Ishikawa K
Stem Cells; 1994 May; 12(3):329-38. PubMed ID: 7521243
[TBL] [Abstract][Full Text] [Related]
10. SPARC promotes the development of erythroid progenitors.
Luo Z; Luo P; Yu Y; Zhao Q; Zhao X; Cheng L
Exp Hematol; 2012 Oct; 40(10):828-36. PubMed ID: 22687753
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow.
De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; Ley P; de Hemptinne D; Stryckmans P
Stem Cells; 1995 May; 13(3):281-8. PubMed ID: 7613494
[TBL] [Abstract][Full Text] [Related]
12. Evidence for downregulation of erythropoietin receptor in bone marrow erythroid cells of patients with chronic idiopathic neutropenia.
Pontikoglou C; Liapakis G; Pyrovolaki K; Papadakis M; Bux J; Eliopoulos GD; Papadaki HA
Exp Hematol; 2006 Oct; 34(10):1312-22. PubMed ID: 16982324
[TBL] [Abstract][Full Text] [Related]
13. Transitional change of colony stimulating factor requirements for erythroid progenitors.
Sawada K; Krantz SB; Dai CH; Sato N; Ieko M; Sakurama S; Yasukouchi T; Nakagawa S
J Cell Physiol; 1991 Oct; 149(1):1-8. PubMed ID: 1719002
[TBL] [Abstract][Full Text] [Related]
14. Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin.
Sieff CA; Emerson SG; Mufson A; Gesner TG; Nathan DG
J Clin Invest; 1986 Jan; 77(1):74-81. PubMed ID: 3511093
[TBL] [Abstract][Full Text] [Related]
15. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
16. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
17. Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors.
Sawada K; Krantz SB; Dai CH; Koury ST; Horn ST; Glick AD; Civin CI
J Cell Physiol; 1990 Feb; 142(2):219-30. PubMed ID: 2154501
[TBL] [Abstract][Full Text] [Related]
18. Identification of three accessory cell populations in human bone marrow with erythroid burst-promoting properties.
Linch DC; Lipton JM; Nathan DG
J Clin Invest; 1985 Apr; 75(4):1278-84. PubMed ID: 3872887
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of mixed colony-forming cells in normal human bone marrow and blood.
Dresch C; Barreau P
Exp Hematol; 1985 Dec; 13(11):1143-51. PubMed ID: 4065263
[TBL] [Abstract][Full Text] [Related]
20. Circulating CFU-E during hematopoietic recovery after allogeneic bone marrow transplantation: relationship to erythroid engraftment.
Vannucchi AM; Bosi A; Lombardini L; Grossi A; Bacci P; Guidi S; Saccardi R; Rossi-Ferrini P
Exp Hematol; 1995 Dec; 23(13):1337-40. PubMed ID: 7498360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
